Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Covington
Dow
Daiichi Sankyo
Moodys
Express Scripts
Johnson and Johnson
UBS
McKinsey
Deloitte
Julphar

Generated: January 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 207266

« Back to Dashboard

NDA 207266 describes BUPIVACAINE HYDROCHLORIDE, which is a drug marketed by Aurobindo Pharma Ltd, Hospira, Sagent Agila, Baxter Hlthcare Corp, Septodont, and Intl Medicated, and is included in twenty-six NDAs. It is available from five suppliers. Additional details are available on the BUPIVACAINE HYDROCHLORIDE profile page.

The generic ingredient in BUPIVACAINE HYDROCHLORIDE is bupivacaine hydrochloride; epinephrine bitartrate. There are eleven drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the bupivacaine hydrochloride; epinephrine bitartrate profile page.
Summary for 207266
Tradename:BUPIVACAINE HYDROCHLORIDE
Applicant:Baxter Hlthcare Corp
Ingredient:bupivacaine hydrochloride
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 207266
Ingredient-typeAmides
Physiological EffectLocal Anesthesia
Suppliers and Packaging for NDA: 207266
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BUPIVACAINE HYDROCHLORIDE bupivacaine hydrochloride INJECTABLE;SPINAL 207266 ANDA Baxter Healthcare Corporation 36000-092 36000-092-10 10 AMPULE in 1 BLISTER PACK (36000-092-10) > 2 mL in 1 AMPULE
BUPIVACAINE HYDROCHLORIDE bupivacaine hydrochloride INJECTABLE;SPINAL 207266 ANDA Baxter Healthcare Corporation 36000-092 36000-092-25 25 AMPULE in 1 BLISTER PACK (36000-092-25) > 2 mL in 1 AMPULE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;SPINALStrength0.75%
Approval Date:Jul 25, 2016TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Healthtrust
Farmers Insurance
Cantor Fitzgerald
Fuji
Baxter
Boehringer Ingelheim
Novartis
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot